Form 4 for OPRX OptimizeRx Corp
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001628280-25-009628 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-01 | OPRX | Odence-Ford Marion | CLO, CHRO | M - OptEx | $0.00 | +771 | 70.5K | +1% | $0 |
| D | 2025-03-04 | 2025-03-01 | OPRX | Odence-Ford Marion | CLO, CHRO | F - Tax | $5.18 | -268 | 70.3K | -0.4% | -$1,388 |
| D | 2025-03-04 | 2025-03-01 | OPRX | Odence-Ford Marion | CLO, CHRO | M - OptEx | $0.00 | -771 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | M | A | 771 | $0.00 | 70,544 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. |
| 2 | Common | Common Stock | 2025-03-01 | F | D | 268 | $5.18 | 70,276 | D | — | — | (F2) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |
| 3 | Derivative | Restricted Stock Units | 2025-03-01 | M | D | 771 | $0.00 | 0 | D | — · — to — | 771 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. (F3) The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date. |